These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38133693)

  • 1. Cytokine profile levels and their relationship with parasitemia and cardiomyopathy in people with Chagas disease in Spain. A prospective observational study.
    Ramos-Rincon JM; Torrús-Tendero D; García-Morante H; Gimeno-Gascón A; Marco F; Gil-Anguita C; Wikman-Jorgensen P; Lucas-Dato A; Rodriguez-Diaz JC; Amador C; Llenas-García J
    Parasitol Res; 2023 Dec; 123(1):66. PubMed ID: 38133693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum IL-10 Levels and Its Relationship with Parasitemia in Chronic Chagas Disease Patients.
    Salvador F; Sánchez-Montalvá A; Martínez-Gallo M; Sulleiro E; Franco-Jarava C; Sao Avilés A; Bosch-Nicolau P; Moure Z; Silgado A; Molina I
    Am J Trop Med Hyg; 2020 Jan; 102(1):159-163. PubMed ID: 31701864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial.
    Moreira OC; Ramírez JD; Velázquez E; Melo MF; Lima-Ferreira C; Guhl F; Sosa-Estani S; Marin-Neto JA; Morillo CA; Britto C
    Acta Trop; 2013 Jan; 125(1):23-31. PubMed ID: 22982466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute Lymphocyte Count: a Predictor of Positive Serum PCR for Trypanosoma cruzi in Patients with Chagas Disease Undergoing Heart Transplantation.
    Wolf PJW; Finger MA; Rossi Neto JM; Santos CC; Mattos VBM; Rossi R; Damiani LP
    Arq Bras Cardiol; 2024 Jun; 121(6):e20230588. PubMed ID: 39016410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Specific
    Gomes Dos Santos A; Watanabe EH; Ferreira DT; Oliveira J; Nakanishi ÉS; Oliveira CS; Bocchi E; Novaes CTG; Cruz F; Carvalho NB; Sato PK; Yamashiro-Kanashiro EH; Pontillo A; de Freitas VLT; Onuchic LF; Shikanai-Yasuda MA
    Front Immunol; 2020; 11():521409. PubMed ID: 33193300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parasitemia Levels in Trypanosoma cruzi Infection in Spain, an Area Where the Disease Is Not Endemic: Trends by Different Molecular Approaches.
    Flores-Chavez MD; Abras A; Ballart C; Ibáñez-Perez I; Perez-Gordillo P; Gállego M; Muñoz C; Moure Z; Sulleiro E; Nieto J; García Diez E; Simón L; Cruz I; Picado A
    Microbiol Spectr; 2022 Oct; 10(5):e0262822. PubMed ID: 36190410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV and Chagas Disease: An Evaluation of the Use of Real-Time Quantitative Polymerase Chain Reaction to Measure Levels of Trypanosoma cruzi Parasitemia in HIV Patients in Cochabamba, Bolivia.
    Reimer-McAtee MJ; Mejia C; Clark T; Terle J; Pajuelo MJ; Cabeza J; Lora MH; Valencia E; Castro R; Lozano D; Bern C; Torrico F; Gilman RH
    Am J Trop Med Hyg; 2021 Aug; 105(3):643-650. PubMed ID: 34398818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in
    Gibaldi D; Vilar-Pereira G; Pereira IR; Silva AA; Barrios LC; Ramos IP; Mata Dos Santos HA; Gazzinelli R; Lannes-Vieira J
    Front Immunol; 2020; 11():306. PubMed ID: 32194558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients.
    Castro-Sesquen YE; Gilman RH; Mejia C; Clark DE; Choi J; Reimer-McAtee MJ; Castro R; Valencia-Ayala E; Flores J; Bowman N; Castillo-Neyra R; Torrico F; Liotta L; Bern C; Luchini A;
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004407. PubMed ID: 26919324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Human CD11b
    Passos LSA; Magalhães LMD; Soares RP; Marques AF; Alves MLR; Giunchetti RC; Nunes MDCP; Gollob KJ; Dutra WO
    Front Immunol; 2018; 9():3015. PubMed ID: 30662439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma cytokine expression is associated with cardiac morbidity in chagas disease.
    Sousa GR; Gomes JA; Fares RC; Damásio MP; Chaves AT; Ferreira KS; Nunes MC; Medeiros NI; Valente VA; Corrêa-Oliveira R; Rocha MO
    PLoS One; 2014; 9(3):e87082. PubMed ID: 24603474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-32
    Braga YLL; Neto JRC; Costa AWF; Silva MVT; Silva MV; Celes MRN; Oliveira MAP; Joosten LAB; Ribeiro-Dias F; Gomes RS; Machado JR
    J Immunol Res; 2022; 2022():7070301. PubMed ID: 35097133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Helminth Infection on the Clinical and Microbiological Presentation of Chagas Diseases in Chronically Infected Patients.
    Salvador F; Sulleiro E; Sánchez-Montalvá A; Martínez-Gallo M; Carrillo E; Molina I
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004663. PubMed ID: 27115603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine serum levels in patients infected by human immunodeficiency virus with and without Trypanosoma cruzi coinfection.
    Rodrigues DB; Correia D; Marra MD; Giraldo LE; Lages-Silva E; Silva-Vergara ML; Barata CH; Rodrigues Junior V
    Rev Soc Bras Med Trop; 2005; 38(6):483-7. PubMed ID: 16410923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine profiling in Chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (a BENEFIT TRIAL sub-study).
    Poveda C; Fresno M; Gironès N; Martins-Filho OA; Ramírez JD; Santi-Rocca J; Marin-Neto JA; Morillo CA; Rosas F; Guhl F
    PLoS One; 2014; 9(3):e91154. PubMed ID: 24608170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Cytokine and Chemokine Profiles of Trypanosoma cruzi-Infected Women During Pregnancy and Its Association With Congenital Transmission.
    Volta BJ; Bustos PL; González C; Natale MA; Perrone AE; Milduberger N; Laucella SA; Bua J
    J Infect Dis; 2021 Sep; 224(6):1086-1095. PubMed ID: 33528501
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Girard MC; Ossowski MS; Muñoz-Calderón A; Fernández M; Hernández-Vásquez Y; Chadi R; Gómez KA
    Front Cell Infect Microbiol; 2021; 11():723549. PubMed ID: 34458163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma cruzi burden, genotypes, and clinical evaluation of Chilean patients with chronic Chagas cardiopathy.
    Apt W; Arribada A; Zulantay I; Saavedra M; Araya E; Solari A; Ortiz S; Arriagada K; Rodríguez J
    Parasitol Res; 2015 Aug; 114(8):3007-18. PubMed ID: 25935204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
    Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
    Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction.
    Basquiera AL; Sembaj A; Aguerri AM; Omelianiuk M; Guzmán S; Moreno Barral J; Caeiro TF; Madoery RJ; Salomone OA
    Heart; 2003 Oct; 89(10):1186-90. PubMed ID: 12975414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.